Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
Authors
Keywords
-
Journal
LANCET
Volume 399, Issue 10324, Pages 530-540
Publisher
Elsevier BV
Online
2022-01-29
DOI
10.1016/s0140-6736(22)00101-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
- (2021) Daniel O. Griffin et al. AIDS REVIEWS
- Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
- (2021) Perrine Janiaud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Brief report: Production of anti‐SARS‐CoV ‐2 hyperimmune globulin from convalescent plasma
- (2021) Peter Vandeberg et al. TRANSFUSION
- Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
- (2021) Philippe Bégin et al. NATURE MEDICINE
- Early Convalescent Plasma for High-Risk Outpatients with Covid-19
- (2021) Frederick K. Korley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
- (2021) Arvind Gharbharan et al. Nature Communications
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
- (2020) Ventura A. Simonovich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
- (2019) Richard T Davey et al. Lancet Respiratory Medicine
- Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection
- (2018) Hillary A Vanderven et al. JOURNAL OF INFECTIOUS DISEASES
- Mass weighted urn design — A new randomization algorithm for unequal allocations
- (2015) Wenle Zhao Contemporary Clinical Trials
- Competing Risks Regression for Stratified Data
- (2010) Bingqing Zhou et al. BIOMETRICS
- Treatment of Argentine hemorrhagic fever
- (2007) Delia A. Enria et al. ANTIVIRAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search